Predictive significance of HER2 intratumoral heterogeneity, determined by simultaneous gene and protein analysis, for resistance to trastuzumab-based treatments for HER2-positive breast cancer
暂无分享,去创建一个
M. Nojima | R. Maruyama | F. Akiyama | R. Horii | P. Banks | H. Nitta | S. Ohno | T. Ueno | Yoshinori Ito | H. Kanda